BR9908411A - Use, in or for the preparation of a composition of at least one inhibitor of retinoic acid activity - Google Patents

Use, in or for the preparation of a composition of at least one inhibitor of retinoic acid activity

Info

Publication number
BR9908411A
BR9908411A BR9908411-2A BR9908411A BR9908411A BR 9908411 A BR9908411 A BR 9908411A BR 9908411 A BR9908411 A BR 9908411A BR 9908411 A BR9908411 A BR 9908411A
Authority
BR
Brazil
Prior art keywords
composition
preparation
inhibitor
retinoic acid
hair
Prior art date
Application number
BR9908411-2A
Other languages
Portuguese (pt)
Inventor
Jean-Daniel Doutremepuich
Carole Marconnet
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BR9908411A publication Critical patent/BR9908411A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • A61Q7/02Preparations for inhibiting or slowing hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/603Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

<B>"UTILIZAçãO, NA OU PARA, PREPARAçãO DE UMA COMPOSIçãO DE PELO MENOS UM INIBIDOR DA ATIVIDADE DO áCIDO RETINóICO"<D> A invenção refere-se a utilização, na ou para, preparação de uma composição cosmética ou farmacêutica, de preferência dermatológica, de pelo menos um inibidor da atividade do ácido retinóico, dita composição estando destinada a retardar ou a impedir o crescimento dos pelos e/ou dos cabelos. Dita composição é igualmente destinada a retardar a queda dos pelos e/ou dos cabelos<B> "USE, ON OR FOR, PREPARATION OF A COMPOSITION OF AT LEAST ONE RETINIC ACID ACTIVITY INHIBITOR" <D> The invention relates to the use, in or for, the preparation of a cosmetic or pharmaceutical composition, preferably dermatological, of at least one inhibitor of the activity of retinoic acid, said composition being destined to retard or prevent the growth of hair and / or hair. Said composition is also intended to delay the fall of hair and / or hair

BR9908411-2A 1998-03-31 1999-03-24 Use, in or for the preparation of a composition of at least one inhibitor of retinoic acid activity BR9908411A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803978A FR2776511B1 (en) 1998-03-31 1998-03-31 USE IN OR FOR THE PREPARATION OF A COMPOSITION OF AT LEAST ONE INHIBITOR OF RETINOIC ACID ACTIVITY
PCT/FR1999/000687 WO1999049838A1 (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss

Publications (1)

Publication Number Publication Date
BR9908411A true BR9908411A (en) 2000-12-05

Family

ID=9524693

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908411-2A BR9908411A (en) 1998-03-31 1999-03-24 Use, in or for the preparation of a composition of at least one inhibitor of retinoic acid activity

Country Status (16)

Country Link
EP (1) EP1066017A1 (en)
JP (1) JP2002509870A (en)
KR (1) KR20010042104A (en)
CN (1) CN1298290A (en)
AR (1) AR015551A1 (en)
AU (1) AU2938899A (en)
BR (1) BR9908411A (en)
CA (1) CA2324899A1 (en)
FR (1) FR2776511B1 (en)
HU (1) HUP0102411A3 (en)
IL (1) IL137859A0 (en)
NO (1) NO20004880L (en)
PL (1) PL343004A1 (en)
RU (1) RU2193877C2 (en)
WO (1) WO1999049838A1 (en)
ZA (1) ZA200004483B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733684B1 (en) * 1995-05-03 1997-05-30 Cird Galderma USE OF RETINOIDS IN A COSMETIC COMPOSITION OR FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION
FR2739777B1 (en) * 1995-10-11 1997-11-14 Cird Galderma LIGAND ANTAGONIST RAR-GAMMA OR AGONIST RAR-ALPHA AS AN APOPTOSIS INHIBITOR
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
CN1255396C (en) * 1996-03-18 2006-05-10 卫材株式会社 Carboxylic acid derivatives having fused rings

Also Published As

Publication number Publication date
HUP0102411A2 (en) 2001-11-28
KR20010042104A (en) 2001-05-25
CN1298290A (en) 2001-06-06
JP2002509870A (en) 2002-04-02
CA2324899A1 (en) 1999-10-07
PL343004A1 (en) 2001-07-30
NO20004880L (en) 2000-11-30
AR015551A1 (en) 2001-05-02
ZA200004483B (en) 2002-02-27
AU2938899A (en) 1999-10-18
HUP0102411A3 (en) 2002-12-28
IL137859A0 (en) 2001-10-31
RU2193877C2 (en) 2002-12-10
WO1999049838A1 (en) 1999-10-07
EP1066017A1 (en) 2001-01-10
FR2776511B1 (en) 2001-05-11
FR2776511A1 (en) 1999-10-01
NO20004880D0 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
BRPI9908182B8 (en) wound healing matrix protein compositions
AR002974A1 (en) Use of at least one cgrp antagonist for the preparation of a cosmetic, pharmaceutical and / or dermatological composition to treat red skin spots of neurogenic origin, composition obtained and cosmetic treatment procedure using said antagonist.
BR9708632A (en) Calcilic compounds
FR2751878B1 (en) USE IN A COMPOSITION OF AN EXTRACT OF AT LEAST ONE LABIEE
EE03741B1 (en) Use of the R-enantiomer of N-propargyl-1-aminoindan, its salts and compositions
HK1034189A1 (en) An acidified composition for topical treatment of nail and skin conditions.
BR9810121A (en) Use of native or esterified petroselinic acid
BR9611802A (en) Pharmaceutical compositions
PT671161E (en) ECTOINE AND ECTOINE DERIVATIVES AS A HUMIDITY DISTRIBUTOR IN COSMETIC PRODUCTS
FR2784294B1 (en) COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTAINING AT LEAST ONE WALL EXTRACT, AT LEAST ONE SCUTELLAR EXTRACT AND AT LEAST ONE SALICYLIC ACID DERIVATIVE
ES2159382T3 (en) STILBENIC COMPOUNDS WITH ADAMANTILO GROUP, COMPOSITIONS THAT CONTAIN THEM AND USES.
BR9709062A (en) Compound, pharmaceutical composition, and, use of a compound.
ES2127490T3 (en) USE OF AN OIL RICH IN PETROSELENIC ACID AS A MOISTURIZING AGENT.
BR9815418A (en) Topical pharmaceutical or cosmetic composition, pharmaceutical, food or cosmetic composition and use of at least one of the agents
BR9913589A (en) Composition, and, cosmetic process to reduce burning or irritation induced by topical application of a composition
EP0824915A3 (en) Preparation of glycoglycerolipids, their use as surfactants and cosmetic or dermatological compositions containing them
HUP0100539A2 (en) Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
FR2775897B1 (en) USE OF STARCH AS AN ACTIVE INGREDIENT FOR THE TREATMENT AND / OR PREVENTION OF THE APPEARANCE OF THE SIGNS OF AGING IN A COSMETIC OR DERMATOLOGICAL COMPOSITION
BR9709154A (en) Use of an inhibitor of retinoic acid activity in a cosmetic composition or for the preparation of a pharmaceutical composition
FR2609395B1 (en) USE OF XANTHIC BASES AS ACTIVE INGREDIENT OF A PHARMACEUTICAL COMPOSITION, ESPECIALLY DERMATOLOGICAL, OR COSMETIC, COMPOSITION ESPECIALLY USEFUL AS BASE MATERIAL FOR THE PREPARATION OF PHARMACEUTICAL OR COSMETIC COMPOSITION AND PHARMACEUTICAL OR COSMETIC COMPOSITION THUS PREPARED
BR0012330A (en) Condom for perishable preparations, particularly for cosmetic and pharmaceutical formulations
EA199700381A1 (en) DIAROMATIC COMPOUNDS PROPINIL OR DIENIL, INTERMEDIATE CONNECTIONS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON THE SPECIFIED CONNECTIONS AND APPLICATION OF COSMETIC COMPOSITIONS
BR9915955A (en) Cosmetic composition for skin care, cosmetic process to treat aged skin and use of 4-chromanone
BR9611642A (en) Pharmaceutical composition compounds and process for the preparation of compounds
BR9708297A (en) Compounds, pharmaceutical composition, composition and use of a cosmetic composition

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTA A 5O, 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 7/02 (2006.01), A61K 8/67 (2006.0